HBQ Stock Overview
Hofseth BioCare ASA operates as a consumer and pet health ingredient supplier and incubator in Norway, the United Kingdom, France, Belgium, Europe, Japan, Asia, and the United States.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 2/6 |
| Dividends | 0/6 |
Hofseth BioCare ASA Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | kr0.17 |
| 52 Week High | kr0.30 |
| 52 Week Low | kr0.15 |
| Beta | 0.43 |
| 1 Month Change | -0.29% |
| 3 Month Change | -21.27% |
| 1 Year Change | -38.73% |
| 3 Year Change | -80.00% |
| 5 Year Change | -35.79% |
| Change since IPO | -31.76% |
Recent News & Updates
Recent updates
Shareholder Returns
| HBQ | DE Biotechs | DE Market | |
|---|---|---|---|
| 7D | -5.7% | 0.8% | 1.2% |
| 1Y | -38.7% | -24.4% | 2.0% |
Return vs Industry: HBQ underperformed the German Biotechs industry which returned -24.4% over the past year.
Return vs Market: HBQ underperformed the German Market which returned 2% over the past year.
Price Volatility
| HBQ volatility | |
|---|---|
| HBQ Average Weekly Movement | 16.6% |
| Biotechs Industry Average Movement | 4.9% |
| Market Average Movement | 4.9% |
| 10% most volatile stocks in DE Market | 10.1% |
| 10% least volatile stocks in DE Market | 2.5% |
Stable Share Price: HBQ's share price has been volatile over the past 3 months.
Volatility Over Time: HBQ's weekly volatility (17%) has been stable over the past year, but is still higher than 75% of German stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2000 | 70 | Jon Odegard | www.hofsethbiocare.com |
Hofseth BioCare ASA operates as a consumer and pet health ingredient supplier and incubator in Norway, the United Kingdom, France, Belgium, Europe, Japan, Asia, and the United States. The company’s products include OmeGo, a salmon oil, which offers the full spectrum of fatty acids and omegas found naturally in fresh whole salmon; ProGo, a bioactive peptide for VMS, metabolism and active nutrition needs; CalGo, an absorbable complex mineral for bone and joint health; CollaGo; and PetGo, a non-soluble protein. Hofseth BioCare ASA was incorporated in 2000 and is headquartered in Ålesund, Norway.
Hofseth BioCare ASA Fundamentals Summary
| HBQ fundamental statistics | |
|---|---|
| Market cap | €70.06m |
| Earnings (TTM) | -€9.05m |
| Revenue (TTM) | €18.54m |
3.8x
P/S Ratio-7.7x
P/E RatioIs HBQ overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| HBQ income statement (TTM) | |
|---|---|
| Revenue | kr218.51m |
| Cost of Revenue | kr165.00m |
| Gross Profit | kr53.51m |
| Other Expenses | kr160.20m |
| Earnings | -kr106.68m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
May 16, 2024
| Earnings per share (EPS) | -0.27 |
| Gross Margin | 24.49% |
| Net Profit Margin | -48.82% |
| Debt/Equity Ratio | 420.9% |
How did HBQ perform over the long term?
See historical performance and comparison